Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00250419
Status:
COMPLETED
Last Update Posted:
2015-02-10
First Post:
2005-11-07
Brief Title:
V930 First in Man FIM Study V930-002COMPLETED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Cancers Expressing HER-2 andor CEA |
Keywords: